Target (CBDY) Research & Development (2015 - 2024)

Target (CBDY) reported Research & Development of $7415.0 for Q1 2024, up 4044.15% quarter-over-quarter from -$188.0 in Q4 2019.

Target (CBDY) Research & Development (2015 - 2024) Analysis & Trends

Target (CBDY) has 6 years of Research & Development data on file, last reported at $7415.0 in Q1 2024.

Research & Development for Q1 2024 came in at $7415.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $7415.0 (changed N/A YoY), and the FY2024 annual result was $7302.0, up 934.28% from the prior year.
Research & Development rose to $7415.0 in Q1 2024 per CBDY's latest filing, from -$188.0 in the prior quarter.
Over five years, Research & Development peaked at $7415.0 in Q1 2024 and troughed at $7415.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	R&D (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	222.00 Mn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	180.00 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	138.20 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	934,363.43
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	296.20 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	97.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	103.35 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	39.38 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	46.94 Mn
10	Target	-	-	191,787.00	-

Download Data